Abstract: The present disclosure relates to the technical field of alien invasive species control, in particular to use of 4-nitro-3-(trifluoromethyl)phenol in killing or controlling Pomacea canaliculata, a method for killing or controlling the Pomacea canaliculata, and a molluscicide. The present disclosure provides use of 4-nitro-3-(trifluoromethyl)phenol in killing or controlling Pomacea canaliculata. The 4-nitro-3-(trifluoromethyl)phenol can effectively control the Pomacea canaliculata with a low cost. In the present disclosure, the results of examples show that: the 4-nitro-3-(trifluoromethyl)phenol has an obvious killing effect on the Pomacea canaliculata, showing a control effect comparable to that of niclosamide, a commonly-used molluscicide for killing the Pomacea canaliculata.

Abstract: The present disclosure discloses a walking power control system for wolfberry picking, including a frame, a turntable, rotating rods, first gears, second gear, gear racks, supporting rods, hydraulic motors, a front traveling wheel, a left traveling wheel and a right traveling wheel. In the present disclosure, hydraulic motors rotate to drives three traveling wheels to rotate, thereby driving the frame to move, when it is necessary to turn, a turntable is rotated, the turntable rotates to drive two first gears to rotate, and the two first gears rotate to drive the supporting rods to rotate, thereby driving the left traveling wheel and the right traveling wheel to rotate, so that the traveling direction of the frame is changed. The picking speed of wolfberries is greatly improved, thereby improving the working efficiency and saving a lot of human resources.

Abstract: The invention relates to methods to modulate liver fibrosis in a subject by administering an activin inhibitor to the subject. In embodiments of the invention, the activin inhibitor can be an activin A antibody or fragment thereof, an activin B antibody or fragment thereof or both an activin A and activin B antibody or fragments thereof. The methods described can be used to treat or modulate liver fibrosis caused by several diseases or disorders including: autoimmune hepatitis, biliary obstruction, iron overload nonalcoholic fatty liver disease, which includes nonalcoholic fatty liver and nonalcoholic steatohepatitis, viral hepatitis B, hepatitis C, alcoholic liver disease or the long-term consumption of alcohol.